Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-3-2
pubmed:abstractText
Silymarin is a mixture of flavonolignans extracted from the milk thistle. Silymarin contains several molecules, including silibinin A, silibinin B, isosilibinin A, isosilibinin B, silicristin, and silidianin. Intravenous infusion of silibinin induces dose-dependent reduction of hepatitis C virus (HCV) RNA levels. The aim of this study was to test the principal isomers contained in silymarin preparations for their ability to inhibit HCV enzymatic functions and replication in different models.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1528-0012
pubmed:author
pubmed:copyrightInfo
Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
138
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1112-22
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
pubmed:affiliation
Research Team Pathophysiology and Therapy of Chronic Viral Hepatitis, INSERM U955, Créteil, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't